Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1997-4-22
|
pubmed:databankReference | |
pubmed:abstractText |
The human blood group Rh antigens are expressed by proteins encoded by a pair of highly homologous genes located at chromosome 1p34-36. One of the genes (RHCE) encodes Rh CcEe antigens, while the other (RHD) the D antigen. Point mutations in the RHCE gene generate the C/c and E/e polymorphisms, while it has been shown that an RHD gene deletion can generate the D-negative phenotype. We have analyzed intron 4 of the RHCE and RHD genes and have defined the site of an RHD-specific deletion located in this intron. Using a multiplex RHD typing assay, which combines a reverse polymerase chain reaction (PCR) primer, which straddles this RHD-specific sequence, and a pair of primers located in exon 10 of the RHD gene, we have analyzed 357 different genomic DNA samples derived from individuals expressing D+, D-, weak D, and partial D phenotypes. Of these, we have noted a significant discordance with our multiplex PCR assay in the D- phenotypes dCcee and dccEe (which have been previously described) and weak D phenotypes. Our results suggest that in five serologically D- individuals we have identified an apparently intact RHD gene. Sequence analysis of transcripts obtained from one of these individuals (of phenotype dCCee) illustrates the presence of full-length RHD transcripts, which have a point mutation at nucleotide 121 (C --> T), which generates an in-frame stop codon (Gln41Stop). Thus, we describe a different molecular basis for generating the D- phenotype to the complete RHD gene deletion described previously. We also show that there are discordances with serotype and the multiplex assay in weak D and partial D phenotypes, indicating that the underlying molecular basis can be heterogeneous. Existing Rh D PCR assays assume the complete absence of the RHD gene in D- phenotypes. We describe a different molecular basis for generating the D- phenotype to the complete RHD gene deletion described previously.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2568-77
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:9116304-Amino Acid Sequence,
pubmed-meshheading:9116304-Base Sequence,
pubmed-meshheading:9116304-Chromosome Deletion,
pubmed-meshheading:9116304-Chromosomes, Human, Pair 1,
pubmed-meshheading:9116304-Cloning, Molecular,
pubmed-meshheading:9116304-Genes,
pubmed-meshheading:9116304-Genetic Variation,
pubmed-meshheading:9116304-Humans,
pubmed-meshheading:9116304-Introns,
pubmed-meshheading:9116304-Molecular Sequence Data,
pubmed-meshheading:9116304-Phenotype,
pubmed-meshheading:9116304-Point Mutation,
pubmed-meshheading:9116304-Polymerase Chain Reaction,
pubmed-meshheading:9116304-Rh-Hr Blood-Group System,
pubmed-meshheading:9116304-Terminator Regions, Genetic
|
pubmed:year |
1997
|
pubmed:articleTitle |
Evidence of genetic diversity underlying Rh D-, weak D (Du), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene.
|
pubmed:affiliation |
International Blood Group Reference Laboratory, Southmead, Bristol, UK.
|
pubmed:publicationType |
Journal Article
|